1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
Research Article
You have full text access to this OnlineOpen article
Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis
Article first published online: 12 DEC 2002
DOI: 10.1002/art.10685
Copyright © 2002 by the American College of Rheumatology
1529-0131/asset/cover.gif?v=1&s=104d5c2bb8ef72deba26790b855af7ab80697a0e "Arthritis & Rheumatism")
Additional Information
How to Cite
Harrison, B. J., Silman, A. J., Hider, S. L. and Herrick, A. L. (2002), Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis. Arthritis & Rheumatism, 46: 3312–3316. doi: 10.1002/art.10685
Publication History
- Issue published online: 12 DEC 2002
- Article first published online: 12 DEC 2002
- Manuscript Accepted: 26 AUG 2002
- Manuscript Received: 19 APR 2002
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan, Scandinavian Journal of Rheumatology, 2011, 1
- 2, , , , , , Cigarette smoking in patients with systemic sclerosis, Arthritis & Rheumatism, 2011, 63, 1Direct Link:
- 3, , , , , , , , , , , Cigarette smoking is not a risk factor for systemic sclerosis, Arthritis & Rheumatism, 2011, 63, 10Direct Link:
- 4, , , , Modeling smoking in systemic sclerosis: A comparison of different statistical approaches, Arthritis Care & Research, 2011, 63, 4Direct Link:
- 5, , , , , , , , Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis, Arthritis & Rheumatism, 2011, 63, 3Direct Link:
- 6, , Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis, Arthritis & Rheumatism, 2010, 62, 9Direct Link:
- 7, , , Determinants of Morbidity and Mortality of Systemic Sclerosis in Canada, Seminars in Arthritis and Rheumatism, 2010, 39, 4, 269
- 8, , Digital Ischemic Loss in Systemic Sclerosis, International Journal of Rheumatology, 2010, 2010, 1
- 9, , , Effects of tobacco smoke on immunity, inflammation and autoimmunity, Journal of Autoimmunity, 2010, 34, 3, J258
- 10, Management of Raynaud’s Phenomenon in the Patient with Connective Tissue Disease, Current Treatment Options in Cardiovascular Medicine, 2010, 12, 2, 185
- 11, , , , , , , , , A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost, Clinical Rheumatology, 2009, 28, 7, 807
- 12
- 13, , , Smoking and atherosclerotic cardiovascular disease: Part II: Role of cigarette smoking in cardiovascular disease development, Biomarkers in Medicine, 2009, 3, 5, 617
- 14, , , , Antioxidants and smoking in autoimmune disease — Opposing sides of the seesaw?, Autoimmunity Reviews, 2008, 8, 2, 165
- 15, Diagnosis and Management of Scleroderma Peripheral Vascular Disease, Rheumatic Disease Clinics of North America, 2008, 34, 1, 89
- 16, , Raynaud's Phenomenon: Etiology and Management, Reumatolog Ãa Cl Ãnica (English Edition), 2008, 4, 2, 59
- 17, , , , Raynaud's phenomenon: Pathogenesis and management, Journal of the American Academy of Dermatology, 2008, 59, 4, 633
- 18, Raynaud’s phenomenon, Current Treatment Options in Cardiovascular Medicine, 2008, 10, 2, 146
- 19, , , Tobacco smoking and autoimmune rheumatic diseases, Nature Clinical Practice Rheumatology, 2007, 3, 12, 707
- 20, Traitement de la sclérodermie systémique (en dehors de l’hypertension artérielle pulmonaire), La Revue de Médecine Interne, 2007, 28, S277
- 21, Treatment of Raynaud’s phenomenon: New insights and developments, Current Rheumatology Reports, 2003, 5, 2, 168